Your browser doesn't support javascript.
Interferon-ß Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2.
Bastard, Paul; Lévy, Romain; Henriquez, Soledad; Bodemer, Christine; Szwebel, Tali-Anne; Casanova, Jean-Laurent.
  • Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France. paul.bastard@institutimagine.org.
  • Lévy R; University of Paris, Imagine Institute, Paris, EU, France. paul.bastard@institutimagine.org.
  • Henriquez S; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. paul.bastard@institutimagine.org.
  • Bodemer C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
  • Szwebel TA; University of Paris, Imagine Institute, Paris, EU, France.
  • Casanova JL; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, EU, France.
J Clin Immunol ; 41(5): 931-933, 2021 07.
Article in English | MEDLINE | ID: covidwho-1384521
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Incontinentia Pigmenti / COVID-19 Limits: Humans Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-021-01023-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Incontinentia Pigmenti / COVID-19 Limits: Humans Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-021-01023-5